Medical Devices

Point-of-Care Testing (POCT) Devices Market, Size, Share, Growth, Future Prospects, and Competitive Analysis, 2025-2033

Published October 5, 2026 /Updated November 12, 2026 /No. of pages: 279 /Report ID: TD-20261005119

PDF Excel PowerPoint

Market snapshot

Point-of-Care Testing (POCT) Devices Market Size, 2024-2033

USD Billion

2024202520262027202820292030203120322033

The figures are in the full report. Request a free sample ↗

Market overview

Study Period2024 - 2033
Historic Year2024
Base Year2025
Forecast Period2026 - 2033
Market Size (Base Year)USD 40.0 Billion
Market Size (Forecast Year)USD 63.8 Billion
Growth Rate (CAGR)6.0 %
Fastest Growing MarketAsia-Pacific
Largest MarketNorth America
Market ConcentrationMedium

Inside the report

Pages from the sample report. Figures are shown as XX here; the full report has them.

See the full sample: Request a free sample ↗

About this report

This report covers the point-of-care testing (POCT) devices market: diagnostic tests and devices used at or near the patient, outside central laboratories, including glucose monitoring devices, blood gas and electrolyte analysers, coagulation monitors and haematology, cardiovascular, infectious disease and pregnancy and fertility tests, used in hospitals and clinics, ambulatory care, homes and diagnostic centres. The market is valued at manufacturers' selling prices.

Point-of-care tests give results within minutes, allowing faster treatment decisions in emergency rooms, intensive care, doctors' offices, pharmacies and at home.

Diabetes, faster diagnosis and decentralised care are driving the market while reimbursement and accuracy concerns are restraints

The rising number of people with diabetes and the spread of continuous glucose monitors, including to people with type 2 diabetes and over-the-counter users, make glucose monitoring the largest and fastest-growing part of the market.

Hospitals and clinics use point-of-care tests to speed diagnosis in emergency and critical care, and health systems are moving testing into pharmacies, clinics and homes. New molecular tests bring laboratory-quality infectious disease testing to the point of care.

However, reimbursement limits, quality and accuracy requirements, price competition in blood glucose strips and the fall in respiratory testing after the pandemic weigh on parts of the market.

Glucose monitoring devices and homecare settings account for the largest shares

The global Point-of-Care Testing (POCT) Devices market is mainly classified based on product type and end user. By product type, the market is segmented into coagulation monitoring devices, blood gas and electrolyte analysers, haematology testing kits, cardiovascular testing kits, infectious disease testing kits, pregnancy and fertility testing kits, glucose monitoring devices and others. By end user, it covers hospitals and clinics, ambulatory care settings, homecare settings, diagnostic centres and others.

Glucose monitoring devices account for about half of the market, led by continuous glucose monitors, followed by infectious disease tests, blood gas and electrolyte analysers, and cardiovascular and coagulation tests.

Homecare settings account for the largest share because of glucose monitoring and pregnancy tests, while hospitals and clinics are the largest users of professional point-of-care analysers.

Interesting Facts of Point-of-Care Testing (POCT) Devices Market:

  • A continuous glucose monitor measures sugar levels every few minutes through a tiny filament under the skin.
  • Some continuous glucose monitors can now be bought without a prescription.
  • Blood gas analysers in intensive care units give results in about a minute.
  • Home pregnancy tests are among the most widely used point-of-care tests.
  • Some point-of-care tests can detect flu or strep throat in a doctor's office within minutes.

North America is expected to account for the largest share of the Point-of-Care Testing (POCT) Devices industry, while Asia-Pacific is expected to grow fastest

North America is the largest market, led by the United States, with high use of continuous glucose monitors and point-of-care testing in hospitals, clinics and pharmacies.

Europe is the second-largest market with strong glucose monitoring and hospital point-of-care use. Asia-Pacific is expected to grow fastest as diabetes rises and healthcare access expands in China and India, while South America and the Middle East and Africa are smaller but growing markets.

Global Point-of-Care Testing (POCT) Devices Market Key Players:

Some of the major competitors in the global Point-of-Care Testing (POCT) Devices market include Abbott Laboratories, Dexcom, Inc., F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Danaher Corporation (Radiometer, Cepheid), Werfen, QuidelOrtho Corporation, bioMérieux SA, Becton, Dickinson and Company (BD), Medtronic (MiniMed), Ascensia Diabetes Care, Nova Biomedical Corporation, Sekisui Diagnostics LLC, Nipro Corporation, Sysmex Corporation, and Sinocare.

The Point-of-Care Testing (POCT) Devices market is moderately concentrated. Abbott and Dexcom lead in continuous glucose monitoring, Roche, Ascensia and Chinese makers in blood glucose meters, and Abbott, Roche, Siemens Healthineers, Danaher's Radiometer and Cepheid, Werfen, QuidelOrtho, bioMérieux and BD in professional point-of-care testing.

The following are some recent market developments:

  • In January 2026, Abbott reported strong growth in continuous glucose monitor sales for 2025.
  • In January 2026, Abbott reported lower rapid diagnostics sales for 2025 as demand for respiratory tests fell.
  • In 2026, Dexcom reported higher revenue for 2025 but gave a 2026 outlook below analysts' expectations.
  • In September 2025, the US Department of Commerce opened a national security investigation into imports of medical equipment, devices and consumables.
  • In January 2026, Abbott reported 2025 sales for its point-of-care diagnostics business, which includes handheld blood analysers used in hospitals.

Frequently asked questions about the global Point-of-Care Testing (POCT) Devices market

Q: What is the current size of the global Point-of-Care Testing (POCT) Devices market?

Ans: The Point-of-Care Testing (POCT) Devices market was valued at USD 40.0 billion in 2025 and is projected to reach USD 63.8 billion by 2033, at a CAGR of 6.0% during the forecast period.

Q: What are the major opportunities in the Point-of-Care Testing (POCT) Devices industry?

Ans: Continuous glucose monitoring for type 2 diabetes and over-the-counter use, molecular point-of-care tests, pharmacy testing and connected devices are major opportunities.

Q: What is the major growth driving factor for the Point-of-Care Testing (POCT) Devices industry?

Ans: The rising number of people with diabetes and the shift of testing closer to patients are the main growth drivers.

Q: Which region is expected to have the largest share of the Point-of-Care Testing (POCT) Devices market?

Ans: North America is expected to have the largest share, while Asia-Pacific is expected to grow fastest.

Q: Which product type segment will dominate the Point-of-Care Testing (POCT) Devices market?

Ans: Glucose monitoring devices are expected to dominate the market.

Table of contents

  1. Point-of-Care Testing (POCT) Devices Market - Introduction

    1. Market Definition
    2. Research Objective and Scope of the Report
  2. Point-of-Care Testing (POCT) Devices Market - Research Methodology

  3. Point-of-Care Testing (POCT) Devices Market - Executive Summary

    1. Market Snippet, By Product Type
    2. Market Snippet, By End-User
    3. Market Snippet, By Region
  4. Point-of-Care Testing (POCT) Devices Market Dynamics

    1. Market Dynamics
      1. Drivers
      2. Restraints
    2. Market Trends & Opportunities
    3. Porter's Five Analysis
    4. Regulatory Analysis
    5. Key Developments
    6. Patent Analysis
  5. Point-of-Care Testing (POCT) Devices Market - Medical Device Tariff Impact Analysis

  6. Point-of-Care Testing (POCT) Devices Market - By Product Type

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      2. Market Attractiveness Index, By Product Type
    2. Coagulation Monitoring Devices
      1. Introduction
      2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    3. Blood Gas & Electrolyte Analyzers
    4. Hematology Testing Kits
    5. Cardiovascular Testing Kits
    6. Infectious Disease Testing Kits
    7. Pregnancy & Fertility Testing Kits
    8. Glucose Monitoring Devices
    9. Others
  7. Point-of-Care Testing (POCT) Devices Market - By End-User

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      2. Market Attractiveness Index, By End-User
    2. Hospitals & Clinics
      1. Introduction
      2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    3. Ambulatory Care Settings
    4. Homecare Settings
    5. Diagnostic Centers
    6. Others
  8. Point-of-Care Testing (POCT) Devices Market - By Region

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country (The U.S., Canada, Mexico)
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country (Germany, The U.K., France, Italy, Spain, Rest of Europe)
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country (Brazil, Argentina, Rest of South America)
    5. Asia-Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country (China, India, Japan, Australia, Rest of Asia-Pacific)
    6. The Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  9. Competitive Landscape

    1. Competitive Scenario
    2. Comparative Product Portfolio Analysis
    3. Market Positioning/Share Analysis
    4. Mergers and Acquisitions Analysis
    5. Company Profiles (company overview, product portfolio, financials, SWOT analysis)
      1. Abbott Laboratories
      2. Dexcom, Inc.
      3. F. Hoffmann-La Roche Ltd.
      4. Siemens Healthineers AG
      5. Danaher Corporation (Radiometer, Cepheid)
      6. Werfen
      7. QuidelOrtho Corporation
      8. bioMérieux SA
      9. Becton, Dickinson and Company (BD)
      10. Medtronic (MiniMed)
      11. Ascensia Diabetes Care
      12. Nova Biomedical Corporation
      13. Sekisui Diagnostics LLC
      14. Nipro Corporation
      15. Sysmex Corporation
      16. Sinocare
  10. Appendix

    1. About Us and Services
    2. Related Reports
    3. Contact Us

Impact of US medical device tariff investigations

In September 2025 the US Department of Commerce opened a national security investigation into imports of medical equipment, devices, consumables and protective equipment. Point-of-care testing relies heavily on imported test strips, cartridges, sensors and analysers, so tariffs resulting from the investigation could raise costs.

Leading suppliers have so far managed tariff effects through pricing and local production, and large manufacturers have expanded US production of glucose sensors and diagnostic tests.

Demand for continuous glucose monitors remains strong as use spreads to people with type 2 diabetes and over-the-counter sensors, while demand for rapid respiratory tests has fallen back after the pandemic years.

This report assumes that any tariffs are partly absorbed and partly passed on without a lasting fall in demand, and treats broad device tariffs and reimbursement changes as the main risks.

Backed by 1 million+ hours of research experience across the industries we cover.

10+

Domains covered

16+

Countries covered

100%

Committed to timely delivery

100+

Projects delivered

Point-of-Care Testing (POCT) Devices Market, Size, Share, Growth, Future Prospects, and Competitive Analysis, 2025-2033